GPR183 and inflammatory bowel disease: Here we showed increased expression of the genes encoding both of these receptors and CH25H, important for the GPR183 ligand, in the intestine of IBD patients and mouse models of inflammation, with increased GPR183 in patients resistant to TNF blockade.